How to build a global marijuana flower brand: Q&A with Cookies co-founder Berner

National cannabis brands are common across most sectors — edibles, vape pens, pre-rolls.

But one sector is lacking in that regard: Flower.

No hallucination: Psychedelics could be next cannabis-like boom

Investors as well as cannabis companies and executives are rushing into psychedelics, a multibillion-dollar opportunity that reminds some of the early days of marijuana – although this infant industry could play out much differently.

Curaleaf enters European cannabis market with $286 million acquisition of Emmac Life Sciences

Curaleaf Holdings said Tuesday it signed a $286 million definitive agreement to acquire London-based medical marijuana company Emmac Life Sciences, giving the Massachusetts-based multistate operator a major foothold in the European cannabis market and a leg up on rival businesses.

United Nations approves WHO recommendation to reschedule cannabis in historic vote

The United Nations Commission on Narcotic Drugs (CND) on Wednesday accepted a World Health Organization (WHO) recommendation to remove cannabis and cannabis resin from Schedule IV of the 1961 Single Convention on Narcotic Drugs.